Projects

ICMR - Improving Glycemic Control

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Dr. Farah Naaz Fathima, Dr. Prem K Mony

Authors

Dr. Farah Naaz Fathima, Dr. Prem K Mony, Dr. B Ramakrishna Goud, Dr. Twinkle Agrawal, Dr. Pooja R Sridhar, Dr. Sumithra, Dr. Avita Rose Johnson

Project Status

ongoing